<acronym id="1sis7"><sup id="1sis7"></sup></acronym><span id="1sis7"><sup id="1sis7"><nav id="1sis7"></nav></sup></span>
      <ruby id="1sis7"><menu id="1sis7"></menu></ruby>
      <ol id="1sis7"><output id="1sis7"></output></ol>
    1. <ol id="1sis7"><blockquote id="1sis7"></blockquote></ol>
    2. <strong id="1sis7"><output id="1sis7"></output></strong>
    3. <span id="1sis7"><blockquote id="1sis7"><nav id="1sis7"></nav></blockquote></span>

      1. <optgroup id="1sis7"><i id="1sis7"><del id="1sis7"></del></i></optgroup>
        1. Zybio had successfully developed SARS-CoV-2 Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)

          January 26,2020 Zybio News

          Since the outbreak of the coronavirus infection in December 2019, the pandemic has become increasingly severe. On January 12, 2020, the World Health Organization (WHO) officially named the new coronavirus "2019-nCoV".

          Compared with the SARS coronavirus, the new type of coronavirus is relatively weaker in toxicity, but it is more contagious. At the same time, in the incubation period the virus is also contagious, which increases the difficulty of prevention and control, diagnosis and treatment. According to the “Clinical management of severe acute respiratory infection when novel coronavirus (?2019-nCoV)? infection is suspected: interim guidance” from WHO, it recommends RT-PCR for novel coronavirus detection as the first choice.

          Molecular diagnostic methods to directly detect viral nucleic acids can minimize the detection window period, and it is the most effective means of screening and diagnosis currently.

          Based on the novel coronavirus genome sequence jointly published by many domestic and foreign research institutions in the "Global Shared Influenza Virus Database GISAID", Zybio established a special R&D team to conduct the research and development of the detection kit in the first time.

          Recently, Zybio had successfully developed SARS-CoV-2 Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method). The launch of this product greatly helps the rapid virus detection and early differential diagnosis of infected patients.

          image.pngimage.png

          Zybio provides rapid clinical solutions for the detection of novel coronaviruses. This solution includes "SARS-CoV-2 Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)", "Nucleic Acid Extraction kit (Magnetic Bead Method)" and Automatic Nucleic Acid Isolation System.

          Zybio's Nucleic Acid Extraction Kit can achieve batch extraction of 32 people in 9 minutes. With the "SARS-CoV-2 Nucleic Acid Detection Kit", the overall detection time is shortened to about 1 hour, which is greatly simplify the process and shorten the operation time.

          In the future, Zybio will continue to pay attention to the development of the pandemic, and fully assist in the fight against SARS-CoV-2!


          亚洲国产精品综合久久2007,91精品国产91久久久久久无码,久久精品国产,99精品亚洲,久久94精品福利久久久久久